Ankui Yang | Head and Neck Surgery | Sun Yat-sen University Cancer Center-Sun Yat-sen University Cancer Center

Name: Ankui Yang

Title: Professor, Director of the Department of Head and Neck Surgery

Email:

Phone:

Profile

Dr. Ankui Yang has extensive experience and expertise in developing surgical treatment for Head and Neck Cancer, including the treatment for thyroid cancer, throat cancer, tongue cancer, salivary gland cancer, paranasal sinus cancer.

Interests

Mouth and Maxillofacial Tumors

Education

1981 - 1987 MB, Sun Yat-sen University

1995 – 1998 MM, Sun Yat-sen University

Publications

(2010-2014)

1. Treatment and prognosis in sinonasal mucosal melanoma: A retrospective analysis of 65 patients from a single cancer center. Head Neck. 2014 May;36(5):675-81.

2. Irradiation of the recipient site does not adversely affect successful free flap transfer in the repair of head and neck defects after salvage surgery for recurrent nasopharyngeal carcinoma originally treated with radiotherapy. J PlastSurg Hand Surg. 2013;47(1):40-5.

3. Combined hyoid bone flap in laryngeal reconstruction after extensive partial laryngectomy for laryngeal cancer. Eur Arch Otorhinolaryngol.2013,270(4):1455-1462.

4. Anatomical study and modified incision of the infrahyoidmyocutaneous flap. Eur Arch Otorhinolaryngol.2013,270(2):675-80.

5. Treatment and Prognosis of Anaplastic Thyroid Carcinoma: Experience from a Single Institution in China. PLoS One. 2013;8(11):e80011.

6. High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270(3):1009-17.

7. Mandibular lingual release approach: an appropriate approach for total or subtotal glossectomy. Head Neck Oncol. 2013 6;5(2):11.

8. ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study. Med Oncol (2012) 29:1409–1417.

9. Elective neck dissection in clinical stage I squamous cell carcinoma of the tongue: Does it improve regional control or survival time? Oral Oncol. 2011 Feb;47(2):136-41

10. Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas. Curr Opin Otolaryngol Head Neck Surg, 2011 Apr,19:87-91.

11. Herbal interactions with anticancer drugs: mechanistic and clinical considerations.Curr Med Chem,2010,17(16):1635-78.

12. Modulators of Multidrug Resistance Proteins in the Management of Anticancer and Antimicrobial Drug Resistance and the Treatment of Inflammatory Disease.Curr Top Med Chem,2010,10(17):1732-56.

13. Primary salivary gland type carcinoma of the nasopharynx: Therapeutic outcomes and prognostic factors.HEAD & NECK,2010,32(4):435-44.

Last updated on: August, 2014 by International Office, Sun Yat-sen University Cancer Center

Our Experts